<SEC-DOCUMENT>0001104659-22-050452-index.html : 20220426
<SEC-HEADER>0001104659-22-050452.hdr.sgml : 20220426
<ACCEPTANCE-DATETIME>20220426171903
ACCESSION NUMBER:		0001104659-22-050452
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20220614
FILED AS OF DATE:		20220426
DATE AS OF CHANGE:		20220426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		22855423

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm223590-1_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: tm223590-1_def14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm223590d1-pxy_proxy1bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: tm223590d1-pxy_proxy1bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm223590d1-pxy_proxy2bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tm223590d1-pxy_proxy2bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm223590d1-pxy_proxy3bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tm223590d1-pxy_proxy3bw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm223590d1-pxy_proxy4bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tm223590d1-pxy_proxy4bw.jpg

</DOCUMENT>
</SEC-DOCUMENT>